Novel approach to temozolomide resistance in malignant glioma: connexin43-directed therapeutics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel approach to temozolomide resistance in malignant glioma: connexin43-directed therapeutics

Published:2018-08 Issue: Volume:41 Page:79-88
ISSN:1471-4892
Container-title:Current Opinion in Pharmacology
language:en
Short-container-title:Current Opinion in Pharmacology

Author:

Grek Christina L,Sheng Zhi,Naus Christian C,Sin Wun Chey,Gourdie Robert G,Ghatnekar Gautam G

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference69 articles.

1. Brain cancer: tumour cells on neighbourhood watch;Sontheimer;Nature,2015

2. Heterogeneity maintenance in glioblastoma: a social network;Bonavia;Cancer Res,2011

3. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

4. MGMT gene silencing and benefit from temozolomide in glioblastoma;Hegi;N Engl J Med,2005

5. MGMT-independent temozolomide resistance in pediatric glioblastoma cells associated with a PI3-kinase-mediated HOX/stem cell gene signature;Gaspar;Cancer Res,2010

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chlorpromazine overcomes temozolomide resistance in glioblastoma by inhibiting Cx43 and essential DNA repair pathways;Journal of Translational Medicine;2024-07-18

2. Connexin 43 drives glioblastoma cancer stem cell phenotypes through a WNK lysine-deficient protein kinase 1-c-MYC signaling axis;2024-07-03

3. Chlorpromazine Overcomes Temozolomide Resistance in Glioblastoma by inhibiting Cx43 and Essential DNA Repair Pathways;2024-05-20

4. Cell Death, by Any Other Name…;Cells;2024-02-10

5. Decreased eukaryotic initiation factors expression upon temozolomide treatment—potential novel implications for eIFs in glioma therapy;Journal of Neuro-Oncology;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3